Exercise modifies α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor expression in striatopallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse

Journal of Neuroscience Research

Volumn 91, Issue 11, 2013, Pages 1492-1507

  Kintz, N ^a   Petzinger, G M ^a,b   Akopian, G ^c   Ptasnik, S ^a   Williams, C ^b   Jakowec, M W ^a,b   Walsh, J P ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

AMPA receptors; Exercise; MPTP; Parkinson's disease; Plasticity

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CHLORPHENIRAMINE MALEATE PLUS PHENYLEPHRINE; DOPAMINE; GLUTAMATE RECEPTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CELL SURFACE; CONTROLLED STUDY; CORPUS STRIATUM; EXERCISE; GLOBUS PALLIDUS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVE CELL; NERVE CELL PLASTICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PATHOPHYSIOLOGY; POSTSYNAPTIC DENSITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SUBUNIT; STIMULATION; TREADMILL EXERCISE; WESTERN BLOTTING;

AMPA RECEPTORS; EXERCISE; MPTP; PARKINSON'S DISEASE; PLASTICITY;

ANIMALS; BLOTTING, WESTERN; BRAIN; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; NEURONAL PLASTICITY; NEURONS; PARKINSONIAN DISORDERS; PATCH-CLAMP TECHNIQUES; PHYSICAL CONDITIONING, ANIMAL; RECEPTORS, AMPA;

EID: 84884722813     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23260     Document Type: Article

References (64)

1. 2+ channels. J Neurophysiol 87:157-165.
2. Akopian G, Walsh JP. 2006. Pre- and postsynaptic contributions to age-related alterations in corticostriatal synaptic plasticity. Synapse 60:223-238.
3. Akopian G, Walsh JP. 2007. Reliable long-lasting depression interacts with variable short-term facilitation to determine corticostriatal paired-pulse plasticity. J Physiol 580:225-240.
4. Akopian G, Musleh W, Smith R, Walsh JP. 2000. Functional state of corticostriatal synapses determines their expression of short- and long-term plasticity. Synapse 38:271-280.
5. Akopian G, Crawford C, Beal MF, Cappelletti M, Jakowec MW, Petzinger GM, Zheng L, Gheorghe SL, Reichel CM, Chow R, Walsh JP. 2008. Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 hr after 3-nitropropionic-acid-induced chemical hypoxia. J Neurosci 28:9585-9597.
6. Alt A, Nisenbaum ES, Bleakman D, Witkin JM. 2006. A role for AMPA receptors in mood disorders. Biochem Pharmacol 71:1273-1288.
7. Ba M, Kong M, Yang H, Ma G, Lu G, Chen S, Liu Z. 2006. Changes in subcellular distribution and phosphorylation of GluR1 in lesioned striatum of 6-hydroxydopamine-lesioned and l-dopa-treated rats. Neurochem Res 31:1337-1347.
8. Betarbet R, Porter RH, Greenamyre JT. 2000. GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation. J Neurochem 74:1166-1174.
9. Brown AM, Deutch AY, Colbran RJ. 2005. Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism. Eur J Neurosci 22:247-256.
10. Buldakova SL, Vorobjev VS, Sharonova IN, Samoilova MV, Magazanik LG. 1999. Characterization of AMPA receptor populations in rat brain cells by the use of subunit-specific open channel blocking drug, IEM-1460. Brain Res 846:52-58.
11. Calabresi P, Picconi B, Tozzi A, Di Filippo M. 2007. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci 30:211-219.
12. 2-eGFP BAC transgenic mice. J Neurosci 32:9124-9132.
13. Chang PK, Verbich D, McKinney RA. 2012. AMPA receptors as drug targets in neurological disease-advantages, caveats, and future outlook. Eur J Neurosci 35:1908-1916.
14. 2 receptor knockout mice. Proc Natl Acad Sci U S A 98:1970-1975.
15. Conrad KL, Tseng KY, Uejima JL, Reimers JM, Heng LJ, Shaham Y, Marinelli M, Wolf ME. 2008. Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving. Nature 454:118-121.
16. 2+-permeable AMPA receptors: synaptic plasticity and beyond. Curr Opin Neurobiol 16:288-297.
17. Dell'anno MT, Pallottino S, Fisone G. 2013. mGlu5R promotes glutamate AMPA receptor phosphorylation via activation of PKA/DARPP-32 signaling in striatopallidal medium spiny neurons. Neuropharmacology 66:179-186.
18. Deng YP, Xie JP, Wang HB, Lei WL, Chen Q, Reiner A. 2007. Differential localization of the GluR1 and GluR2 subunits of the AMPA-type glutamate receptor among striatal neuron types in rats. J Chem Neuroanat 33:167-112.
19. Dosemeci A, Tao-Cheng JH, Vinade L, Jaffe H. 2006. Preparation of postsynaptic density fraction from hippocampal slices and proteomic analysis. Biochem Biophys Res Commun 339:687-694.
20. Feligioni M, Holman D, Haglerod C, Davanger S, Henley JM. 2006. Ultrastructural localisation and differential agonist-induced regulation of AMPA and kainate receptors present at the presynaptic active zone and postsynaptic density. J Neurochem 99:549-560.
21. 2A receptor heteromers as key players in striatal function. Front Neuroanat 5:36.
22. Fisher BE, Petzinger GM, Nixon K, Hogg E, Bremmer S, Meshul CK, Jakowec MW. 2004. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned mouse basal ganglia. J Neurosci Res 77:378-390.
23. Gittis AH, Leventhal DK, Fensterheim BA, Pettibone JR, Berke JD, Kreitzer AC. 2011. Selective inhibition of striatal fast-spiking interneurons causes dyskinesias. J Neurosci 31:15727-15731.
24. Gong S, Yang XW, Li C, Heintz N. 2002. Highly efficient modification of bacterial artificial chromosomes (BACs) using novel shuttle vectors containing the R6Kgamma origin of replication. Genome Res 12:1992-1998.
25. Gong S, Zheng C, Doughty ML, Losos K, Didkovsky N, Schambra UB, Nowak NJ, Joyner A, Leblanc G, Hatten ME, Heintz N. 2003. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425:917-925.
26. Greger IH, Esteban JA. 2007. AMPA receptor biogenesis and trafficking. Curr Opin Neurobiol 17:289-297.
27. Gubellini P, Pisani A, Centonze D, Bernardi G, Calabresi P. 2004. Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases. Prog Neurobiol 74:271-300.
28. Hahn CG, Banerjee A, Macdonald ML, Cho DS, Kamins J, Nie Z, Borgmann-Winter KE, Grosser T, Pizarro A, Ciccimaro E, Arnold SE, Wang HY, Blair IA. 2009. The post-synaptic density of human postmortem brain tissues: an experimental study paradigm for neuropsychiatric illnesses. PLoS One 4:e5251.
29. Hernandez-Echeagaray E, Starling AJ, Cepeda C, Levine MS. 2004. Modulation of AMPA currents by D2 dopamine receptors in striatal medium-sized spiny neurons: are dendrites necessary? Eur J Neurosci 19:2455-2463.
30. Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S. 1995. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Neurodegeneration 4:257-269.
31. Jakowec MW, Fox AJ, Martin LJ, Kalb RG. 1995. Quantitative and qualitative changes in AMPA receptor expression during spinal cord development. Neuroscience 67:893-907.
32. Jakowec MW, Jackson-Lewis V, Chen X, Langston JW, Przedborski S. 1998. The postnatal development of AMPA receptors in the basal ganglia of the rat. Dev Neurobiol 20:19-33.
33. Jakowec MW, Donaldson DM, Barba J, Petzinger GM. 2001. The postnatal expression of α-synuclein in the substantia nigra and striatum of the rodent. Dev Neurosci 23:91-99.
34. Jakowec MW, Nixon K, Hogg L, McNeill T, Petzinger GM. 2004. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurodegeneration in the mouse nigrostriatal pathway. J Neurosci Res 76:539-550.
35. Johnson MW, Chotiner JK, Watson JB. 1997. Isolation and characterization of synaptoneurosomes from single rat hippocampal slices. J Neurosci Methods 77:151-156.
36. Kessels HW, Malinow R. 2009. Synaptic AMPA receptor plasticity and behavior. Neuron 61:340-350.
37. Kessels HW, Kopec CD, Klein ME, Malinow R. 2009. Roles of stargazin and phosphorylation in the control of AMPA receptor subcellular distribution. Nat Neurosci 12:888-896.
38. 2-EGFP mice. J Neurosci 31:126-132.
39. 2+ permeability of AMPARs at cerebellar synapses. Nat Neurosci 8:768-775.
40. Matamales M, Bertran-Gonzalez J, Salomon L, Degos B, Deniau JM, Valjent E, Herve D, Girault JA. 2009. Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice. PLoS ONE 4:e4770.
41. 2 BAC transgenic mice. J Neurosci 32:9119-9123.
42. 2A receptors during early stages of a rat model of Huntington disease. Exp Neurol 232:76-80.
43. Ouattara B, Hoyer D, Gregoire L, Morissette M, Gasparini F, Gomez-Mancilla B, Di Paolo T. 2010. Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias. Neuroscience 167:1160-1167.
44. 2+-permeable AMPA receptors in neurological disorders. Trends Neurosci 20:464-470.
45. Peterson JD, Goldberg JA, Surmeier DJ. 2012. Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion. Neurobiol Dis 45:409-416.
46. Petzinger GM, Walsh JP, Akopian G, Hogg E, Abernathy A, Arevalo P, Turnquist P, Vuckovic M, Fisher BE, Togasaki DM, Jakowec MW. 2007. Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J Neurosci 27:5291-5300.
47. Picconi B, Pisani A, Barone I, Bonsi P, Centonze D, Bernardi G, Calabresi P. 2005. Pathological synaptic plasticity in the striatum: implications for Parkinson's disease. Neurotoxicology 26:779-783.
48. Rossmann M, Sukumaran M, Penn AC, Veprintsev DB, Babu MM, Greger IH. 2011. Subunit-selective N-terminal domain associations organize the formation of AMPA receptor heteromers. EMBO J 30:959-971.
49. Rusakov DA, Savtchenko LP, Zheng K, Henley JM. 2011. Shaping the synaptic signal: molecular mobility inside and outside the cleft. Trends Neurosci 34:359-369.
50. Shen W, Flajolet M, Greengard P, Surmeier DJ. 2008. Dichotomous dopaminergic control of striatal synaptic plasticity. Science 321:848-851.
51. Shin J, Shen F, Huguenard J. 2007. PKC and polyamine modulation of GluR2-deficient AMPA receptors in immature neocortical pyramidal neurons of the rat. J Physiol 581:679-691.
52. Siviy SM, Crawford CA, Akopian G, Walsh JP. 2011. Dysfunctional play and dopamine physiology in the Fischer 344 rat. Behav Brain Res 220:294-304.
53. Stellwagen D, Beattie EC, Seo JY, Malenka RC. 2005. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 25:3219-3228.
54. Surmeier DJ, Ding J, Day M, Wang Z, Shen W. 2007. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 30:228-235.
55. Tang KC, Low MJ, Grandy DK, Lovinger DM. 2001. Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc Natl Acad Sci U S A 98:1255-1260.
56. Tao-Cheng JH, Crocker VT, Winters CA, Azzam R, Chludzinski J, Reese TS. 2011. Trafficking of AMPA receptors at plasma membranes of hippocampal neurons. J Neurosci 31:4834-4843.
57. Taverna S, Ilijic E, Surmeier DJ. 2008. Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease. J Neurosci 28:5504-5512.
58. VanLeeuwen JE, Petzinger GM, Walsh JP, Akopian GK, Vuckovic M, Jakowec MW. 2010. Altered AMPA receptor expression with treadmill exercise in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J Neurosci Res 88:650-668.
59. 1F]fallypride. Mov Disord 25:2777-2784.
60. Wang WW, Cao R, Rao ZR, Chen LW. 2004. Differential expression of NMDA and AMPA receptor subunits in DARPP-32-containing neurons of the cerebral cortex, hippocampus and neostriatum of rats. Brain Res 998:174-183.
61. Williams C, Mehrian Shai R, Wu Y, Hsu YH, Sitzer T, Spann B, McCleary C, Mo Y, Miller CA. 2009. Transcriptome analysis of synaptoneurosomes identifies neuroplasticity genes overexpressed in incipient Alzheimer's disease. PLoS ONE 4:e4936.
62. Wullner U, Brouillet E, Isacson O, Young AB, Penney JB. 1993. Glutamate receptor binding sites in MPTP-treated mice. Exp Neurol 121:284-287.
63. 2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc Natl Acad Sci U S A 103:8251-8256.
64. Zhu ZT, Shen KZ, Johnson SW. 2002. Pharmacological identification of inward current evoked by dopamine in rat subthalamic neurons in vitro. Neuropharmacology 42:772-781.